Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease

BACKGROUND AND AIMS: Inflammatory bowel disease [IBD], consisting of Crohn’s disease [CD] and ulcerative colitis [UC], is a relapsing-remitting illness. Treat-to-target IBD management strategies require monitoring of gastrointestinal inflammation. This study aimed to investigate faecal myeloperoxida...

Descripción completa

Detalles Bibliográficos
Autores principales: Swaminathan, Akhilesh, Borichevsky, Grace M, Edwards, Teagan S, Hirschfeld, Esther, Mules, Thomas C, Frampton, Chris M A, Day, Andrew S, Hampton, Mark B, Kettle, Anthony J, Gearry, Richard B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721461/
https://www.ncbi.nlm.nih.gov/pubmed/35803583
http://dx.doi.org/10.1093/ecco-jcc/jjac098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721461/
https://www.ncbi.nlm.nih.gov/pubmed/35803583
http://dx.doi.org/10.1093/ecco-jcc/jjac098

Ejemplares similares